CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $12,000 | -58.6% | 2,332 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $29,000 | +26.1% | 2,332 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $23,000 | 0.0% | 2,332 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $23,000 | +76.9% | 2,332 | +52.7% | 0.00% | 0.0% |
Q1 2020 | $13,000 | -7.1% | 1,527 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $14,000 | +55.6% | 1,527 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | -50.0% | 1,527 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $18,000 | 0.0% | 1,527 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $18,000 | -5.3% | 1,527 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $19,000 | -17.4% | 1,527 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $23,000 | -11.5% | 1,527 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $26,000 | -25.7% | 1,527 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $35,000 | -12.5% | 1,527 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $40,000 | +122.2% | 1,527 | +28.6% | 0.00% | +100.0% |
Q3 2017 | $18,000 | +5.9% | 1,187 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $17,000 | -15.0% | 1,187 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $20,000 | – | 1,187 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |